Literature DB >> 16125146

STin2 variant and family history of suicide as significant predictors of suicide completion in major depression.

Catalina Lopez de Lara1, Alexandre Dumais, Guy Rouleau, Alain Lesage, Mimi Dumont, Nadia Chawky, Martin Alda, Chawki Benkelfat, Gustavo Turecki.   

Abstract

BACKGROUND: Suicide is the most serious outcome of major depression, yet not all depressed patients will commit suicide. Genes, along with other factors, might account for this difference. Serotonergic alterations have been observed in suicide and depression and impulsive-aggressive behaviors. Therefore, we aimed to identify predictors of suicide, considering genetic variation at the serotonin transporter (5-HTT) gene.
METHODS: We investigated the 5-HTT gene-linked polymorphic region (5-HTTLPR) and intron 2 (STin2) variants of this gene and their relationship to behavioral and clinical risk factors for suicide in a sample of depressed suicides (n =106) and depressed control subjects (n =152), diagnosed by means of proxy-based interviews.
RESULTS: We found a significant association of suicide completion with having at least one copy of the STin2 10 allele [chi(2)(1) = 10.833, p = .002]. No differences were found for the 5-HTTLPR variable number of tandem repeats. After controlling for behavioral and clinical risk factors for suicide, the STin2 variant remained a significant predictor of suicide in major depression when jointly considered with a family history of suicide (odds ratio 5.560, 95% confidence interval 1.057-29.247).
CONCLUSIONS: The STin2 locus might account, at least in part, for the observed familial aggregation of suicidal behavior. These results should be further explored in families where clustering of suicidal behavior is observed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16125146     DOI: 10.1016/j.biopsych.2005.06.021

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  22 in total

Review 1.  The interpersonal theory of suicide.

Authors:  Kimberly A Van Orden; Tracy K Witte; Kelly C Cukrowicz; Scott R Braithwaite; Edward A Selby; Thomas E Joiner
Journal:  Psychol Rev       Date:  2010-04       Impact factor: 8.934

Review 2.  Pharmacogenetics of antidepressant response.

Authors:  Stefano Porcelli; Antonio Drago; Chiara Fabbri; Sara Gibiino; Raffaella Calati; Alessandro Serretti
Journal:  J Psychiatry Neurosci       Date:  2011-03       Impact factor: 6.186

Review 3.  Toward a biosignature for suicide.

Authors:  Maria A Oquendo; Gregory M Sullivan; Katherin Sudol; Enrique Baca-Garcia; Barbara H Stanley; M Elizabeth Sublette; J John Mann
Journal:  Am J Psychiatry       Date:  2014-10-31       Impact factor: 18.112

4.  Interactions between serotonin transporter gene haplotypes and quality of mothers' parenting predict the development of children's noncompliance.

Authors:  Michael J Sulik; Nancy Eisenberg; Kathryn Lemery-Chalfant; Tracy L Spinrad; Kassondra M Silva; Natalie D Eggum; Jennifer A Betkowski; Anne Kupfer; Cynthia L Smith; Bridget Gaertner; Daryn A Stover; Brian C Verrelli
Journal:  Dev Psychol       Date:  2011-11-07

5.  Life stressors and 5-HTTLPR interaction in relation to midpregnancy depressive symptoms among African-American women.

Authors:  Jeanette M Scheid; Claudia B Holzman; Nicole Jones; Karen H Friderici; Katherine A Jernigan; Laura L Symonds; Alla Sikorskii; Rachel Fisher
Journal:  Psychiatr Genet       Date:  2011-12       Impact factor: 2.458

6.  Acute and posttraumatic stress symptoms in a prospective gene x environment study of a university campus shooting.

Authors:  Kristina B Mercer; Holly K Orcutt; Jeffrey F Quinn; Caitlin A Fitzgerald; Karen N Conneely; Richard T Barfield; Charles F Gillespie; Kerry J Ressler
Journal:  Arch Gen Psychiatry       Date:  2011-09-05

Review 7.  How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems.

Authors:  Dennis L Murphy; Meredith A Fox; Kiara R Timpano; Pablo R Moya; Renee Ren-Patterson; Anne M Andrews; Andrew Holmes; Klaus-Peter Lesch; Jens R Wendland
Journal:  Neuropharmacology       Date:  2008-09-11       Impact factor: 5.250

8.  Clinical implications of genetic variation in the serotonin transporter promoter region: a review.

Authors:  Nicole S Luddington; Anitha Mandadapu; Margaret Husk; Rif S El-Mallakh
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

9.  Incomplete coverage of candidate genes: a poorly considered bias.

Authors:  Antonio Drago; Diana De Ronchi; Alessandro Serretti
Journal:  Curr Genomics       Date:  2007-11       Impact factor: 2.236

10.  Positron Emission Tomographic Imaging of the Serotonergic System and Prediction of Risk and Lethality of Future Suicidal Behavior.

Authors:  Maria A Oquendo; Hanga Galfalvy; Gregory M Sullivan; Jeffrey M Miller; Matthew M Milak; M Elizabeth Sublette; Sebastian Cisneros-Trujillo; Ainsley K Burke; Ramin V Parsey; J John Mann
Journal:  JAMA Psychiatry       Date:  2016-10-01       Impact factor: 21.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.